Example research questions, but not limited to:
Does offering CAB LA for PrEP to broad populations result in:
a) increased overall PrEP uptake, adherence and/or persistence
b) a neutral or positive impact on tolerability (incl. metabolic, bone + renal markers) compared to oral PrEP options.